Early this morning, an analyst at Leerink Swann boosted his price target on shares of Savient Pharma (Nasdaq: SVNT) amid ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE